A new Alzheimer’s drug has been approved. But should you take it?

The FDA has granted accelerated approval to the first new drug in nearly two decades for Alzheimer’s disease. But there are potential side effects, and results of studies of this drug have been mixed. It is not yet known whether the drug truly works, or how effective it will be, so the approval is contingent on the drug’s maker conducting further studies over the next several years.

Content restricted. Requires subscription